File this under “Up, up and away!”
Spending on cancer medicines in the U.S. has doubled since 2012, reaching nearly $50 billion last year, thanks to a recent rush of new treatments that were launched at high prices. And this may be only the beginning: Spending is expected to roughly double — to $100 billion — by 2022, or from 12 percent to 15 percent annually, according to a new analysis.
About the Author Reprints
From the closing paragraph – “Looking more broadly, IQVIA found ….” given the current state of the news, might it be more appropriate to use “IQVIA says they found …” since their numbers can be ‘a bit off?’ Admittedly, Commissioner G used different wording but one wonders about their numbers.